Drug record
What four public record sets show for ondansetron. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.058 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $141.8 million | Details |
| FDA recall records | 24 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Ondansetron Hcl 4 Mg Tablet: pharmacies pay about $0.058 each, or $1.74 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| ONDANSETRON 4 MG/5 ML SOLUTION | Generic | $0.288 per mL | — | Oct 21, 2026 |
| ONDANSETRON 4 MG/5 ML SOLUTION CUP | Generic | $0.288 per mL | — | Oct 21, 2026 |
| ONDANSETRON 40 MG/20 ML VIAL | Generic | $0.193 per mL | — | Oct 21, 2026 |
| ONDANSETRON HCL 4 MG TABLET | Generic | $0.058 per each | $1.74 | Oct 21, 2026 |
| ONDANSETRON HCL 4 MG/2 ML VIAL | Generic | $0.177 per mL | — | Nov 11, 2026 |
| ONDANSETRON HCL 8 MG TABLET | Generic | $0.077 per each | $2.30 | Oct 21, 2026 |
| ONDANSETRON ODT 4 MG TABLET | Generic | $0.123 per each | $3.69 | Oct 21, 2026 |
| ONDANSETRON ODT 8 MG TABLET | Generic | $0.180 per each | $5.39 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $141.8 million for the 2 products below. That is up 26% from $112.8 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Ondansetron ODT Ondansetron | $72.9 million | 2,945,288 | $14.79 | $24.76 | $50.6 million |
| Ondansetron HCl* Ondansetron HCl | $68.9 million | 2,252,504 | $16.48 | $30.58 | $62.2 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Ondansetron HCl.
Recalls reported to the FDA that name this drug.
The FDA has 24 recall records that name ondansetron in the product description (23 Class II · 1 Class III). 2 are still marked ongoing.
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
Reason: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01
Reason: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25
Reason: Failed pH Specifications
ONDANSETRON 8MG IN NS 100ML, antimetic, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Reason: Lack of sterility assurance
Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30
Reason: cGMP deviations: Temperature abuse
Ondansetron Hydrochloride, 1 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0127-30.
Reason: Lack of assurance of sterility.
ONDANSETRON HCL 4MG 30; NDC/UPC 65862018730; RX; TABLETS
Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
ONDANSETRON 8 MG / 50 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
Reason: Lack of Assurance of Sterility
ONDANSETRON 2 MG/ML INJECTION SOLUTION (PFV), 2 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0158-02
Reason: Lack of Assurance of Sterility
ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0157-20
Reason: Lack of Assurance of Sterility
Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC, Lake Zurich, IL 60047, NDC 63323-374-20
Reason: Failed Impurities/Degradation Specifications.
Ondansetron 8 mg tablet NDC 57237-0076-30 28 days supply
Reason: Lack of Processing Controls.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for ondansetron. This page is public-record information, not medical advice.